trans-2-(4-chloro-3-fluoro-phenyl)cyclopropanecarboxylic acid - Names and Identifiers
trans-2-(4-chloro-3-fluoro-phenyl)cyclopropanecarboxylic acid - Physico-chemical Properties
Molecular Formula | C10H8ClFO2
|
Molar Mass | 214.62 |
Storage Condition | Room Temprature |
trans-2-(4-chloro-3-fluoro-phenyl)cyclopropanecarboxylic acid - Introduction
(1R,2R)-rel-2-(4-chroo-3-fluorophenyl) cyclopropane-1-carboxylic acid is an organic compound containing a cyclopropane ring and a carboxylic acid group in its chemical structure. The following is a description of the properties, uses, preparation and safety information of the compound:
Nature:
-Appearance: A solid compound.
-Melting point: may vary according to experimental conditions.
-Solubility: Soluble in some organic solvents, such as dimethyl sulfoxide and dichloromethane.
Use:
(1R,2R)-rel-2-(4-choro-3-fluorophenyl) cyclopropane-1-carboxylic acid has certain uses in the pharmaceutical field. It is often used as an intermediate substance for the synthesis of other organic compounds or drugs. The particular use will depend on the structure of the other chemical groups and the desired reaction.
Method:
The preparation method of (1R,2R)-rel-2-(4-chroo-3-fluorophenyl) cyclopropane-1-carboxylic acid can be achieved through a series of organic synthesis reactions. Specific synthetic routes include selective substituted cyclopropane compounds and carboxylation reactions.
Safety Information:
- (1R,2R)-rel-2-(4-choro-3-fluorophenyl) cyclopropane-1-carboxylic acid may be harmful to human health, such as irritating skin and eyes.
-Avoid direct contact with skin and eyes when using, and avoid inhaling its dust.
-During operation, proper safety measures should be taken, such as wearing protective gloves, goggles and dust masks, and ensuring that the workplace has good ventilation facilities.
-When using and handling the compound, it should be operated in accordance with relevant chemical safety operating procedures and guidelines to ensure the safety and health of personnel.
Last Update:2024-04-09 02:00:51